当前位置:首页 - 行情中心 - 汇宇制药-W(688553) - 财务分析 - 现金流量表

汇宇制药-W

(688553)

  

流通市值:46.69亿  总市值:57.57亿
流通股本:3.44亿   总股本:4.24亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金295,333,237.741,169,003,551.67944,767,630.14567,479,781.3
收到的税费返还229,173.3516,557,417.0715,917,077.671,710,444
收到其他与经营活动有关的现金51,001,923.74105,921,407.0277,607,395.2135,607,050.27
经营活动现金流入的平衡项目00-0.010
经营活动现金流入小计346,564,334.831,291,482,375.761,038,292,103.01604,797,275.57
购买商品、接受劳务支付的现金102,321,191.67169,507,856.83175,307,739.12100,821,799.44
支付给职工以及为职工支付的现金69,376,372.82262,619,402.77190,599,318.58134,558,765.76
支付的各项税费17,099,91255,241,446.0372,766,748.6957,885,476.21
支付其他与经营活动有关的现金155,204,935.33561,158,075.22437,373,564.09271,085,737.96
经营活动现金流出的平衡项目0.01000
经营活动现金流出小计344,002,411.831,048,526,780.85876,047,370.48564,351,779.37
经营活动产生的现金流量净额平衡项目0.01000
经营活动产生的现金流量净额2,561,923.01242,955,594.91162,244,732.5340,445,496.2
二、投资活动产生的现金流量:
收回投资收到的现金40,000,0001,578,000,0001,181,000,000931,000,000
取得投资收益收到的现金1,100,496.1120,554,005.3817,163,443.5810,392,755.55
处置固定资产、无形资产和其他长期资产收回的现金净额-98,99585,8005,800
投资活动现金流入的平衡项目0000
投资活动现金流入小计41,100,496.111,598,653,000.381,198,249,243.58941,398,555.55
购建固定资产、无形资产和其他长期资产支付的现金38,596,312.19128,180,390.42110,797,716.0184,132,211.51
投资支付的现金190,000,0001,200,015,133.84953,035,710.55673,035,710.55
投资活动现金流出的平衡项目0000
投资活动现金流出小计228,596,312.191,328,195,524.261,063,833,426.56757,167,922.06
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-187,495,816.08270,457,476.12134,415,817.02184,230,633.49
三、筹资活动产生的现金流量:
取得借款收到的现金156,100,000385,000,000385,000,000345,000,000
收到其他与筹资活动有关的现金173,203,500271,393,025.01212,833,941.6898,427,722.22
筹资活动现金流入平衡项目0000
筹资活动现金流入小计329,303,500656,393,025.01597,833,941.68443,427,722.22
偿还债务支付的现金270,000,000326,500,000231,933,710201,500,000
分配股利、利润或偿付利息支付的现金1,885,967.5198,135,971.894,919,941.0792,190,163.3
支付其他与筹资活动有关的现金115,000,000318,056,546.71237,874,782.01122,874,782.01
筹资活动现金流出平衡项目0000
筹资活动现金流出小计386,885,967.51742,692,518.51564,728,433.08416,564,945.31
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-57,582,467.51-86,299,493.533,105,508.626,862,776.91
四、汇率变动对现金及现金等价物的影响-66,510.81--
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-242,516,360.58427,180,088.34329,766,058.15251,538,906.6
加:期初现金及现金等价物余额2,057,244,246.521,630,064,158.181,630,064,158.181,630,064,158.18
期末现金及现金等价物余额平衡项目-0.01000
期末现金及现金等价物余额1,814,727,885.932,057,244,246.521,959,830,216.331,881,603,064.78
补充资料:
净利润-315,897,222.3-62,205,008.88
资产减值准备-14,813,594.43-259,603.59
固定资产和投资性房地产折旧-75,059,899.59-34,700,074.09
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-75,059,899.59-34,700,074.09
无形资产摊销-2,261,992.82-1,119,668.18
长期待摊费用摊销-921,763.68-460,881.84
处置固定资产、无形资产和其他长期资产的损失-301,236.61-6,594.84
固定资产报废损失-843,877.22-0
公允价值变动损失--239,856,212.2-0
财务费用-13,302,626.07-6,648,242.89
投资损失--13,815,175.53--11,041,322.07
递延所得税-30,311,171.84-4,423,948.35
其中:递延所得税资产减少-29,337,709.28-5,051,698.02
递延所得税负债增加-973,462.56--627,749.67
存货的减少--12,876,292.81--8,590,030.81
经营性应收项目的减少--20,265,210.39--5,563,755.56
经营性应付项目的增加-73,372,590.06--47,193,355.83
其他-1,977,617.36--
现金的期末余额-2,057,244,246.52-1,881,603,064.78
减:现金的期初余额-1,630,064,158.18-1,630,064,158.18
公告日期2025-04-262025-04-262024-10-262024-08-27
审计意见(境内)标准无保留意见
TOP↑